BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19627278)

  • 1. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.
    Niedoszytko M; de Monchy J; van Doormaal JJ; Jassem E; Oude Elberink JN
    Allergy; 2009 Sep; 64(9):1237-45. PubMed ID: 19627278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal anaphylactic sting reaction in a patient with mastocytosis.
    Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
    Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
    González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
    J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recent article on 'Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy' by Niedoszytko et al.
    Kontou-Fili K
    Allergy; 2009 Nov; 64(11):1685. PubMed ID: 19824888
    [No Abstract]   [Full Text] [Related]  

  • 6. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
    Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
    Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
    Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
    Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastocytosis and Hymenoptera venom allergy.
    Ruëff F; Placzek M; Przybilla B
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):284-8. PubMed ID: 16825870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies.
    Stumpf JL; Shehab N; Patel AC
    Ann Pharmacother; 2006 Apr; 40(4):699-703. PubMed ID: 16569814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analysis in predicting the effectiveness of insect venom immunotherapy.
    Niedoszytko M; Bruinenberg M; de Monchy J; Wijmenga C; Platteel M; Jassem E; Oude Elberink JN
    J Allergy Clin Immunol; 2010 May; 125(5):1092-7. PubMed ID: 20334904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of insect-venom anaphylaxis.
    Bilò BM; Bonifazi F
    Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):330-7. PubMed ID: 18596590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New variants of diagnostic procedures and therapeutic methods in insect venom allergy].
    Nittner-Marszalska M
    Pol Merkur Lekarski; 2003 Jun; 14(84):700-2. PubMed ID: 14524309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When can immunotherapy for insect sting allergy be stopped?
    Müller UR; Ring J
    J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insect anaphylaxis: addressing clinical challenges.
    Tracy JM; Lewis EJ; Demain JG
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):332-6. PubMed ID: 21659864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Effectiveness of a 3-Day Rush Insect Venom Immunotherapy Protocol.
    Kranert P; Forchhammer S; Volc S; Stenger F; Schaller M; Fischer J
    Int Arch Allergy Immunol; 2020; 181(2):111-118. PubMed ID: 31794966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.